Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus

Synapse

Volumn 63, Issue 4, 2009, Pages 359-364

  Bianchi, Massimiliano ^a,b,d   Shah, Ajit J ^b   Fone, Kevin C F ^a   Atkins, Alan R ^b   Dawson, Lee A ^b   Heidbreder, Christian A ^c   Hows, Mark E ^b   Hagan, Jim J ^b,c   Marsden, Charles A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GSK   (Italy)

^d Universite Paris Sud   (France)

Author keywords

tubulin; Antidepressants; Depression; Microtubules; Neuronal plasticity; SSRI

Indexed keywords

ALPHA TUBULIN; FLUOXETINE; MONOAMINE;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EX VIVO STUDY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MICROTUBULE; MONOAMINE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN METABOLISM; WESTERN BLOTTING;

ANIMALS; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HIPPOCAMPUS; MALE; MICROTUBULES; RATS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 63049114766     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20614     Document Type: Article

References (27)

1. Bianchi M, Heidbreder C, Crespi F. 2003. Cytoskeletal changes in the hippocampus following restraint stress: Role of serotonin and microtubules. Synapse 49:188-194.
2. Bianchi M, Hagan JJ, Heidbreder CA. 2005. Neuronal plasticity. stress and depression: Involvement of the cytoskeletal microtubular system? Curr Drug Targets CNS Neurol Disord 4:597-611.
3. Bianchi M, Fone KCF, Azmi N, Heidbreder CA, Hagan JJ, Marsden CA. 2006. Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. EJN 24:2894-2902.
4. Caccia S, Fracasso C, Garattini S, Guiso G, Frittoli E, Sarati S. 1992. Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain. Neuropharmacology 44: 250-254.
5. Carboni L, Vighini M, Piubelli C, Castelletti L, Milli A, Domenici E. 2006. Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists. Eur Neuropsychopharmacol 16:521-537.
6. Cheetham SC, Heal DJ. 2000. Antidepressant and anxiolytic drugs. In: Bittar EE, Bittar N, editors. Biological psychiatry. Stanford: JAI Press. pp 551-567.
7. Coppell AL, Pei Q, Zetterstrom TS. 2003. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44:903-910.
8. Dent EW, Gertler FB. 2003. Cytoskeletal dynamics and transport in growth cone motility and axon guidance. Neuron 40:209-227.
9. Dias BG, Banerjee SB, Duman RS, Vaidya VA. 2003. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45:553-563.
10. Donati RJ, Rasenick MM. 2005. Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletalassociated, plasma membrane domains (lipid rafts). Neuropsychopharmacology 30:1238-1245.
11. Drapier D, Bentue-Ferrer D, Laviolle B, Millet B, Allain H, Bourin M, Reymann JM. 2007. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 176:202-209.
12. Durand M, Berton O, Aguerre S, Edno L, Combourieu I, Mormede P, Chaouloff F. 1999. Effects of repeated fluoxetine on anxietyrelated behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. Neuropharmacology 38: 893-907.
13. Erck C, Peris L, Andrieux A, Meissirel C, Gruber AD, Vernet M, Schweitzer A, Saoudi Y, Pointu H, Bosc C, Salin PA, Job D, Wehland J. 2005. A vital role of tubulin-tyrosine-ligase for neuronal organization. PNAS 102:7853-7858.
14. Faure C, Mnie-Filali O, Haddjeri N. 2006. Long-term adaptive changes induced by serotonergic antidepressant drugs. Expert Rev Neurother 6:235-245.
15. Gordon JA, Hen R. 2004. The serotonergic system and anxiety. Neuromolecular Med 5:27-40.
16. Guest PC, Knowles MR, Molon-Noblot S, Salim K, Smith D, Murray F, Laroque P, Hunt SP, De Felipe C, Rupniak NM, McAllister G. 2004. Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodelling. Brain Res 1002: 1-10.
17. Hajszan T, MacLusky NJ, Leranth C. 2005. Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. EJN 21:1299-1303.
18. Miyamoto S, Asakura M, Sasuga Y, Osada K, Bodaiji N, Imafuku J, Aoba A. 1997. Effects of long-term treatment with desipramine on microtubule proteins in rat cerebral cortex. Eur J Pharmacol 333: 279-287.
19. Miró X, Perez-Torres S, Artigas F, Puigdomènech P, Palacios JM, Mengod G. 2002. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment: An in situ hybridization study. Neuropharmacology 43:1148-1157.
20. Paturle-Lafanechere L, Manier M, Trigault N, Pirollet F, Mazarguil H, Job D. 1994. Accumulation of delta 2-tubulin, a major tubulin variant that cannot be tyrosinated, in neuronal tissues and in stable microtubule assemblies. J Cell Sci 107:1529-1543.
21. Perez J, Tinelli D, Brunello N, Racagni G. 1989. cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur J Pharmacol 172:305-316.
22. Perez J, Tinelli D, Bianchi E, Brunello N, Racagni G. 1991. cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology 4:57-64.
23. Peris L, Thery M, Faure J, Saoudi Y, Lafanechere L, Chilton JK, Gordon-Weeks P, Galjart N, Bornens M, Wordeman L, Wehland J, Andrieux A, Job D. 2006. Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends. J Cell Biol 174:839-849.
24. Rapp S, Baader M, Hu M, Jennen-Steinmetz C, Henn FA, Thome J. 2004. Differential regulation of synaptic vesicle proteins by antidepressant drugs. Pharmacogenomics J 4:110-113.
25. Sasse R, Gull K. 1988. Tubulin post-translational modifications and the construction of microtubular organelles in Trypanosoma brucei. J Cell Sci 90:577-589.
26. Thompson MR, Li KM, Clemens KJ, Gurtman CG, Hunt GE, Cornish JL, McGregor IS. 2004. Chronic fluoxetine treatment partly attenuates the longterm anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rat. Neuropsychopharm 29:694-704.
27. Westermann S, Weber K. 2003. Post-translational modifications regulate microtubule function. Nat Rev Mol Cell Biol 4:938-947.